EIC Pathfinder Open Call 2023

The EIC Pathfinder programme aims to support early-stage projects (TRL levels 1 to 4) that have the potential to create new markets and address global changes. With a high-risk/high gain approach, a consortium of minimum 3 partners from academia or industry can work together to develop an innovative technology, based on science-towards-technology breakthrough research, up to the point of proof of principle. The results obtained from the research should lead to top publication, and, it is expected that following the Pathfinder, measures will be taken to ensure the continuation of the project, such as generating Intellectual Property.

Deadline: 7 March 2023

Subsidy: max. €3M

Consortium: a consortium of minimum 3 partners from academia or industry (including SMEs) established in at least 3 different EU Member State countries can work together.

Download our EIC Guide

In our EIC 2023 Programme Guide we have gathered all available information for you. We have assembled the information on deadlines, budgets, consortia & more. A must read if you’re looking for new funding opportunities for your research, R&D or commercialization project.

EIC Guide 2022

EIC Pathfinder Challenges

The EIC Pathfinder open call, is open to any type of technology and research area. Next to that, 5 EIC Pathfinder Challenges have been published for 2023, and have a top-down approach based on a specific topic. The EIC Pathfinder open call eligibility criteria and conditions also apply to the EIC Pathfinder Challenges, but, the information provided below is specific to the Challenges:

Deadline: 18 October 2023

Subsidy: max. €4M

Titles of the 5 EIC Pathfinder Challenges:

  1. Clean and efficient cooling
  2. Architecture, Engineering and Construction digitalisation for a novel triad of design, fabrication, and materials
  3. Precision nutrition
  4. Responsible electronics
  5.  In-space solar energy harvesting for innovative space applications

How far we've come

funding raised
locations worldwide
Catalyze Experts
Network partners

Case: Achilles Therapeutics

Achilles Therapeutics (UK) is pushing the frontier of personalized adoptive T cell therapies. In the first round of the 2022 EIC Pathfinder program, an Achilles-led consortium was awarded €4 million from the “Emerging technologies in cell & gene therapy” Challenge, to develop a proof-of-concept, first-in-class, smart bioprocessing manufacturing platform.


A must-have if you’re interested in getting your business to the next level